MIGS Effective for Black Patients

Clinical Report: MIGS Effective for Black Patients

Overview

Minimally invasive glaucoma surgeries (MIGS) demonstrate significant efficacy in lowering intraocular pressure (IOP) among Black patients, who often present with more advanced glaucoma. The study analyzed data from over 18,000 eyes, revealing that MIGS, particularly the Omni device, required fewer medications compared to cataract surgery alone over a 36-month period.

Background

Glaucoma is a leading cause of blindness, particularly among African-American patients who typically experience more advanced disease at diagnosis. The introduction of MIGS offers a less invasive surgical option that can effectively manage IOP while reducing the medication burden. Understanding the effectiveness of MIGS in diverse populations is crucial for optimizing treatment strategies and improving patient outcomes.

Data Highlights

{'table': {'MIGS (Omni)': {'Medication Classes at Baseline': '1.6-1.9', 'Medication Classes at 36 Months': '0.6-0.9'}, 'MIGS (Hydrus/iStent)': {'Medication Classes at Baseline': '1.6-1.9', 'Medication Classes at 36 Months': '0.8-1.1'}, 'Cataract Surgery Alone': {'Medication Classes at Baseline': '1.6-1.9', 'Medication Classes at 36 Months': '~0.8'}}}

Key Findings

MIGS procedures are effective in lowering IOP in Black patients with glaucoma.
Omni showed the greatest reduction in medication requirements at 36 months compared to other MIGS devices.
Cataract surgery alone resulted in increased IOP over time, highlighting the need for MIGS in this population.
Over 17,000 eyes were identified as candidates for MIGS but only underwent cataract surgery, indicating missed opportunities for treatment.
Long-term data supports the sustained effectiveness of MIGS in reducing both IOP and medication burden.

Clinical Implications

Healthcare providers should consider MIGS as a viable option for Black patients undergoing cataract surgery, given the potential for improved IOP management and reduced medication reliance. This approach addresses an unmet need in a population that often experiences more severe glaucoma.

Conclusion

The findings underscore the importance of incorporating MIGS into treatment plans for Black patients with glaucoma, particularly those undergoing cataract surgery, to enhance clinical outcomes and quality of care.

PentaVision

Glaucoma Physician